Envestnet Portfolio Solutions Inc. trimmed its holdings in Xylem Inc. (NYSE:XYL – Free Report) by 14.1% during the 2nd quarter, Holdings Channel.com reports. The fund owned 2,671 shares of the industrial products company’s stock after selling 439 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Xylem were worth $346,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the business. Hanson & Doremus Investment Management lifted its position in shares of Xylem by 0.9% in the second quarter. Hanson & Doremus Investment Management now owns 8,516 shares of the industrial products company’s stock valued at $1,102,000 after acquiring an additional 77 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. lifted its position in shares of Xylem by 3.0% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 3,450 shares of the industrial products company’s stock valued at $412,000 after acquiring an additional 99 shares in the last quarter. Valley National Advisers Inc. lifted its position in shares of Xylem by 84.9% in the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company’s stock valued at $26,000 after acquiring an additional 101 shares in the last quarter. Ascent Wealth Partners LLC lifted its position in shares of Xylem by 0.7% in the first quarter. Ascent Wealth Partners LLC now owns 14,229 shares of the industrial products company’s stock valued at $1,700,000 after acquiring an additional 101 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in shares of Xylem by 25.1% in the first quarter. Blue Trust Inc. now owns 539 shares of the industrial products company’s stock valued at $64,000 after acquiring an additional 108 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Xylem Trading Up 1.3%
Shares of NYSE XYL opened at $147.82 on Friday. The business’s 50 day moving average is $143.64 and its two-hundred day moving average is $132.24. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $151.16. The stock has a market capitalization of $35.98 billion, a P/E ratio of 38.40, a PEG ratio of 2.49 and a beta of 1.13.
Xylem Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s payout ratio is presently 41.56%.
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at $413,861.72. The trade was a 25.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on XYL. Mizuho boosted their target price on Xylem from $125.00 to $140.00 and gave the stock a “neutral” rating in a research report on Friday, September 12th. Zacks Research upgraded Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. TD Cowen boosted their target price on Xylem from $125.00 to $130.00 and gave the stock a “hold” rating in a research report on Tuesday, August 26th. Citigroup boosted their target price on Xylem from $168.00 to $173.00 and gave the stock a “buy” rating in a research report on Thursday, October 9th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Xylem in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $154.67.
View Our Latest Analysis on Xylem
Xylem Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
- Five stocks we like better than Xylem
- Which Wall Street Analysts are the Most Accurate?
- Warner Bros. Bidding War Potential: How High Could WBD Shares Go?
- Retail Stocks Investing, Explained
- Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash
- What is a penny stock? A comprehensive guide
- O’Reilly Automotive’s Stock Price Uptrend Will Continue in 2026
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
